These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8909339)

  • 1. Misuse of naltrexone.
    Measom MO
    J Clin Psychiatry; 1996 Oct; 57(10):488-9. PubMed ID: 8909339
    [No Abstract]   [Full Text] [Related]  

  • 2. Naltrexone (vivitrol)--a once-monthly injection for alcoholism.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283
    [No Abstract]   [Full Text] [Related]  

  • 3. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
    Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
    Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vivitrex (Alkermes/Cephalon).
    Heading CE
    Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Brown ES; Beard L; Dobbs L; Rush AJ
    Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
    Heidbreder CA; Hagan JJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Naltrexone use in the treatment of alcoholism in Spain].
    Rubio Valladolid G; Espí Martínez F; Sanchís Fortea M; Bravo García De Laguna JL
    Rev Clin Esp; 2002 Aug; 202(8):435-9. PubMed ID: 12199993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Naltrexone].
    Schifano F; Murri R; Gava R
    G Clin Med; 1989 May; 70(5):379-84. PubMed ID: 2666229
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute delirium psychosis induced by naltrexone chlorhydrate].
    Amraoui A; Burgos V; Baron P; Alexandre JY
    Presse Med; 1999 Sep; 28(25):1361-2. PubMed ID: 10506865
    [No Abstract]   [Full Text] [Related]  

  • 11. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research to practice: adoption of naltrexone in alcoholism treatment.
    Thomas CP; Wallack SS; Lee S; McCarty D; Swift R
    J Subst Abuse Treat; 2003 Jan; 24(1):1-11. PubMed ID: 12646325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
    Poser W; Ehrenreich H
    Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alcohol dependence treatment with naltrexone: safety assessment. Observation study group of alcoholic dependence].
    Ochoa Mangado E; Arias Horcajadas F; Torres Hernández MA
    Actas Esp Psiquiatr; 2000; 28(3):161-8. PubMed ID: 11000698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone treatment of combined alcohol and opioid dependence: deterioration of co-morbid major depression.
    Schürks M; Overlack M; Bonnet U
    Pharmacopsychiatry; 2005 Mar; 38(2):100-2. PubMed ID: 15744636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.
    Petrakis IL; Leslie D; Rosenheck R
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1780-4. PubMed ID: 14634494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone abuse potential.
    Lerner AG; Sigal M; Bocalu A; Gelkopf M
    J Nerv Ment Dis; 1992 Nov; 180(11):734-5. PubMed ID: 1431829
    [No Abstract]   [Full Text] [Related]  

  • 20. Naltrexone in the treatment of alcohol dependence: a Canadian trial.
    Romach MK; Sellers EM; Somer GR; Landry M; Cunningham GM; Jovey RD; McKay C; Boislard J; Mercier C; Pépin JM; Perreault J; Lemire E; Baker RP; Campbell W; Ryan D
    Can J Clin Pharmacol; 2002; 9(3):130-6. PubMed ID: 12422250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.